SARS-CoV-2 Vaccines and the Skin

Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Skin reactions; VacinesCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reacciones cutáneas; VacunasCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reaccions cutànies; VacunesVaccines against the severe acute respiratory coronavirus 2, which are the first to be used in humans against any coronavirus, were developed and produced in record time. Dermatologic adverse effects appeared during clinical trials and have also been described in the population since approval. Just as descriptions and categorization of skin manifestations of the coronavirus disease 2019 proved important for understanding the disease itself, characterizing the effects of vaccines may also further that goal. This paper reviews the properties of the different types of vaccines currently available and under development and describes how they interact with the immune system and the clinical signs they may cause. We focus on dermatologic adverse effects reported to date and recommendations for managing them